Latest 10-Q quarterly reports

NYSE
Spruce Power Holding Corporation reported a net loss of $2.9 million for Q1 2026, an improvement from the prior year's $15.3 million loss, driven by significant cost reductions in operations and maintenance and SG&A, despite a slight revenue decrease.
NASDAQ
Solarius Capital Acquisition Corp. reports net income of $1.39 million for Q1 2026, driven by investment income, with no operating revenues as it seeks a business combination.
NYSE
Terra Property Trust reports a substantial net loss for Q1 2026, driven by increased provisions for credit losses and a decline in interest income, while facing significant debt maturities.
NASDAQ
AEye, Inc. has filed its Form 10-Q for the quarter ended March 31, 2026, detailing financial performance and operational updates.
TriLinc Global Impact Fund, LLC filed its Form 10-Q for the quarter ended March 31, 2026, detailing its financial performance and investment portfolio.
NASDAQ
GameSquare Holdings reported a significant increase in revenue for Q1 2026, driven by acquisitions and agency services, but also a substantial widening of its net loss, largely due to digital asset market fluctuations.
OQB
Vivos Inc. reports increased revenue and strategic advancements in its precision radionuclide therapy for both human and animal oncology, alongside ongoing financing efforts.
NASDAQ
Mount Logan Capital Inc. reported a net loss of $5.97 million for the first quarter of 2026, with revenues down 29% year-over-year.
OTC.Pink
WinVest Acquisition Corp. reports continued operational losses and a significant working capital deficit in its Q1 2026 10-Q filing, while extending its business combination deadline.
OTC.Pink
Lifeloc Technologies reported a 1% increase in Q1 2026 revenue to $2.29 million, with a narrowed net loss of $152,713, driven by improved gross profit margins.
AMEX
Calidi Biotherapeutics reports a net loss of $4.1 million for Q1 2026, with a focus on advancing its RedTail platform and securing future funding.
ARC Group Acquisition I Corp files its Q1 2026 Form 10-Q, detailing its formation, initial public offering preparations, and financial status prior to business combination.
NASDAQ
Cibus Inc. reported a 63% increase in Q1 2026 revenue to $1.7 million, driven by collaboration agreements, while net losses narrowed significantly due to cost reductions and a prior year goodwill impairment.
OTC.Pink
Leafbuyer Technologies reports a 35% revenue decline in Q1 2026 due to new FCC regulations impacting SMS/MMS marketing.
NASDAQ
374Water Inc. reported a slight increase in Q1 2026 revenue to $551,155, but continued to face significant operational losses and a going concern warning.
NASDAQ
CapsoVision, Inc. reported flat revenue for the first quarter of 2026 compared to the prior year, with a significant increase in research and development expenses.
NASDAQ
Falcons Beyond Global, Inc. reported a significant revenue increase in Q1 2026, driven by new attractions contracts, but continues to face substantial doubt regarding its ability to continue as a going concern.
OQB
Hepion Pharmaceuticals reports Q1 2026 results with reduced operating expenses but continues to face going concern uncertainties, while also announcing a new diagnostic asset license.
NASDAQ
Health In Tech reported a 9.4% year-over-year revenue increase to $8.8 million for Q1 2026, driven by its SMR segment, but experienced a widening net loss of $1.6 million.
NASDAQ
Comstock Holding Companies reports a 38% increase in revenue for Q1 2026, driven by strong performance in asset and property management services, with net income rising to $1.99 million.
NASDAQ
Innventure, Inc. reported its first-quarter 2026 financial results, showing a significant increase in revenue but a wider net loss compared to the prior year period.
NASDAQ
Stellar V Capital Corp. reports increased net income driven by interest on trust account investments, while continuing its search for a business combination.
OQB
QuoteMedia, Inc. announced its first quarter 2026 financial results, showing a 15% increase in total revenue to $5.53 million, driven by growth in its Portfolio Management Systems and Interactive Content and Data APIs.
NASDAQ
Vine Hill Capital Investment Corp. II reports Q1 2026 net income of $1.615 million, driven by interest income, as it continues its search for an initial business combination.
Newton Golf Company, Inc. reported a net loss of $2.66 million for Q1 2026, with net sales down 18% year-over-year due to manufacturing transition impacts, while also receiving a Nasdaq deficiency letter regarding stockholders' equity.
NASDAQ
BioRestorative Therapies, Inc. reported a narrowed net loss for Q1 2026, improved working capital, and a strengthened cash position, though it faces Nasdaq minimum bid price non-compliance.
NASDAQ
Cenntro Inc. reported a significant decrease in net revenues for the first quarter of 2026, primarily driven by lower vehicle sales, while implementing cost-saving measures.
NASDAQ
Autolus Therapeutics plc announced its first-quarter 2026 financial results, highlighting significant growth in product revenue from AUCATZYL and providing updates on its clinical pipeline.
AleAnna, Inc. announces a significant revenue surge in Q1 2026, driven by increased natural gas production from the Longanesi field, marking a transition to profitability.
NASDAQ
Fortress Biotech Inc. reported a significant net income of $110.4 million for Q1 2026, largely due to a $158.9 million gain from the sale of a Priority Review Voucher.